Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1990 Feb;99(2):285–288. doi: 10.1111/j.1476-5381.1990.tb14695.x

Modulation of seizure susceptibility in the mouse by the strychnine-insensitive glycine recognition site of the NMDA receptor/ion channel complex.

L Singh 1, R J Oles 1, M D Tricklebank 1
PMCID: PMC1917378  PMID: 1691674

Abstract

1. In order to determine whether the strychnine-insensitive glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor/ion channel complex is fully activated in vivo, the ability of the selective glycine receptor agonist, D-serine, to modulate seizure susceptibility in the mouse has been examined. 2. D-Serine (10-200 micrograms per mouse, i.c.v.) dose-dependently increased the potency of NMDLA in inducing seizures in Swiss Webster mice by approximately 3 fold. L-Serine was without significant effect. 3. The potency of pentylenetetrazol in inducing seizures was also enhanced by D-, but not L-serine, although the magnitude of the shift (1.6 fold) was considerably less than for NMDLA. 4. Similar doses of D-serine were also able to block the anticonvulsant effect of the non-selective glycine receptor antagonist, kynurenic acid, against seizures induced by NMDLA, but were without effect on the anticonvulsant effect of the competitive NMDA receptor antagonist, 3-((+)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP). 5. D-Serine completely antagonized the protective effect of the selective glycine receptor antagonist, 7-chlorokynurenic acid, against sound-induced seizures in DBA/2 mice, but was less effective in this model against the less selective antagonist, kynurenic acid. 6 The results indicate that in vivo, NMDA receptors are not maximally potentiated by endogenous glycine and suggest an important involvement of the glycine modulatory site on the NMDA receptor/ion channel complex in the pathophysiology of epilepsy.

Full text

PDF
285

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonhaus D. W., Burge B. C., McNamara J. O. Biochemical evidence that glycine allosterically regulates an NMDA receptor-coupled ion channel. Eur J Pharmacol. 1987 Oct 27;142(3):489–490. doi: 10.1016/0014-2999(87)90096-3. [DOI] [PubMed] [Google Scholar]
  2. Bowery N. G. Glycine-binding sites and NMDA receptors in brain. 1987 Mar 26-Apr 1Nature. 326(6111):338–338. doi: 10.1038/326338a0. [DOI] [PubMed] [Google Scholar]
  3. Bristow D. R., Bowery N. G., Woodruff G. N. Light microscopic autoradiographic localisation of [3H]glycine and [3H]strychnine binding sites in rat brain. Eur J Pharmacol. 1986 Jul 31;126(3):303–307. doi: 10.1016/0014-2999(86)90062-2. [DOI] [PubMed] [Google Scholar]
  4. Croucher M. J., Collins J. F., Meldrum B. S. Anticonvulsant action of excitatory amino acid antagonists. Science. 1982 May 21;216(4548):899–901. doi: 10.1126/science.7079744. [DOI] [PubMed] [Google Scholar]
  5. Danysz W., Wroblewski J. T., Brooker G., Costa E. Modulation of glutamate receptors by phencyclidine and glycine in the rat cerebellum: cGMP increase in vivo. Brain Res. 1989 Feb 13;479(2):270–276. doi: 10.1016/0006-8993(89)91628-4. [DOI] [PubMed] [Google Scholar]
  6. Davies J., Evans R. H., Herrling P. L., Jones A. W., Olverman H. J., Pook P., Watkins J. C. CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity. Brain Res. 1986 Sep 10;382(1):169–173. doi: 10.1016/0006-8993(86)90127-7. [DOI] [PubMed] [Google Scholar]
  7. Ferraro T. N., Hare T. A. Free and conjugated amino acids in human CSF: influence of age and sex. Brain Res. 1985 Jul 8;338(1):53–60. doi: 10.1016/0006-8993(85)90247-1. [DOI] [PubMed] [Google Scholar]
  8. Fletcher E. J., Lodge D. Glycine reverses antagonism of N-methyl-D-aspartate (NMDA) by 1-hydroxy-3-aminopyrrolidone-2 (HA-966) but not by D-2-amino-5-phosphonovalerate (D-AP5) on rat cortical slices. Eur J Pharmacol. 1988 Jun 22;151(1):161–162. doi: 10.1016/0014-2999(88)90711-x. [DOI] [PubMed] [Google Scholar]
  9. Hayes B. A., Balster R. L. Anticonvulsant properties of phencyclidine-like drugs in mice. Eur J Pharmacol. 1985 Oct 29;117(1):121–125. doi: 10.1016/0014-2999(85)90480-7. [DOI] [PubMed] [Google Scholar]
  10. Johnson J. W., Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature. 1987 Feb 5;325(6104):529–531. doi: 10.1038/325529a0. [DOI] [PubMed] [Google Scholar]
  11. Kemp J. A., Foster A. C., Leeson P. D., Priestley T., Tridgett R., Iversen L. L., Woodruff G. N. 7-Chlorokynurenic acid is a selective antagonist at the glycine modulatory site of the N-methyl-D-aspartate receptor complex. Proc Natl Acad Sci U S A. 1988 Sep;85(17):6547–6550. doi: 10.1073/pnas.85.17.6547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Larson A. A., Beitz A. J. Glycine potentiates strychnine-induced convulsions: role of NMDA receptors. J Neurosci. 1988 Oct;8(10):3822–3826. doi: 10.1523/JNEUROSCI.08-10-03822.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Leander J. D., Lawson R. R., Ornstein P. L., Zimmerman D. M. N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs. Brain Res. 1988 May 10;448(1):115–120. doi: 10.1016/0006-8993(88)91107-9. [DOI] [PubMed] [Google Scholar]
  14. Monaghan D. T., Cotman C. W. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci. 1985 Nov;5(11):2909–2919. doi: 10.1523/JNEUROSCI.05-11-02909.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Price G. W., Ahier R. G., Middlemiss D. N., Singh L., Tricklebank M. D., Wong E. H. In vivo labelling of the NMDA receptor channel complex by [3H]MK-801. Eur J Pharmacol. 1988 Dec 13;158(3):279–282. doi: 10.1016/0014-2999(88)90080-5. [DOI] [PubMed] [Google Scholar]
  16. Reynolds I. J., Murphy S. N., Miller R. J. 3H-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc Natl Acad Sci U S A. 1987 Nov;84(21):7744–7748. doi: 10.1073/pnas.84.21.7744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Thomson A. M., Walker V. E., Flynn D. M. Glycine enhances NMDA-receptor mediated synaptic potentials in neocortical slices. Nature. 1989 Mar 30;338(6214):422–424. doi: 10.1038/338422a0. [DOI] [PubMed] [Google Scholar]
  18. Turski L., Meldrum B. S., Turski W. A., Watkins J. C. Evidence that antagonism at non-NMDA receptors results in anticonvulsant action. Eur J Pharmacol. 1987 Apr 7;136(1):69–73. doi: 10.1016/0014-2999(87)90780-1. [DOI] [PubMed] [Google Scholar]
  19. Van Gelder N. M., Sherwin A. L., Rasmussen T. Amino acid content of epileptogenic human brain: focal versus surrounding regions. Brain Res. 1972 May 26;40(2):385–393. doi: 10.1016/0006-8993(72)90141-2. [DOI] [PubMed] [Google Scholar]
  20. Wong E. H., Knight A. R., Ransom R. Glycine modulates [3H]MK-801 binding to the NMDA receptor in rat brain. Eur J Pharmacol. 1987 Oct 27;142(3):487–488. doi: 10.1016/0014-2999(87)90095-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES